<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 16, 1997
U.S. MEDICAL PRODUCTS, INC.
(Exact name of Registrant as specified in its charter)
TEXAS 74-2599718
(State of incorporation) (IRS Employer Identification No.)
1-12954
(Commission File Number)
12201 Technology Boulevard, Suite 100, Austin, Texas
(Address of principal executive offices)
Registrant's telephone number: (512) 257-8787
This document consists of 3 pages of which this is page 1.
<PAGE>
Item 1. Changes in Control of Registrant
None
Item 2. Acquisition or Disposition of Assets
None
Item 3. Bankruptcy or Receivership
Not applicable
Item 4. Changes in Registrant's Certifying Accountants
None
Item 5. Other Events
On June 16, 1997, the Boston Stock Exchange ("Exchange") notified
the Company that it had suspended trading of the Company's common
stock and warrants, and intended to file for immediate delisting of
the Company's securities with the Securities and Exchange
Commission. The Exchange's decision was based upon the Company's
inability to comply with the minimum maintenance requirements
relating to market value of public float and shareholder's equity.
Item 6. Resignations of Registrant's Directors
None
Item 7. Financial Statements and Exhibits
None
Item 8. Changes in Fiscal Year
Not Applicable
2
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
U.S. Medical Products, Inc.
Registrant
Date: June 19, 1997 /s/ Fred Mindermann
---------------------------------
Fred Mindermann
Chief Executive Officer
3
